Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 3921 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Mike Grey appointed Executive Chair of Theolytics' Board of Directors

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024
Related companies:  Theolytics

DNA Nanotechnology Market worth $24.3 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024

Hansa Biopharma publishes 2023 Annual and Sustainability Reports

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024
Related companies:  Hansa Biopharma AB

Sequential, a leading innovator in microbiome testing, is proud to announce a strategic partnership with Eurosafe, a renowned CRO based in France and operating across Europe

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024

Flamingo Therapeutics Appoints Leading Medical Oncologist Ezra Cohen, MD to its Board of Directors

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024

LifeSpeak Inc. Announces Fourth Quarter and Fiscal 2023 Results

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024

ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookbuild Offering and by Way of a Public Offering in France

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Onward Medical N.V.

SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 11.5 MILLION IN AN EQUITY PLACEMENT

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Sequana Medical NV

NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  NMD Pharma A/S

IBA Reports Full Year 2023 Results

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Ion Beam Applications S.A. (IBA)

Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C.

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Valneva SE

Ultimovacs ASA: Annual Report 2023

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Ultimovacs ASA

SINGAPORE'S "HUSTLE CULTURE" TAKES ITS TOLL: THE AIR STATION AND RESMED LAUNCH INITIATIVE TO ADDRESS WORK-INDUCED SLEEP ISSUES

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024

Resolutions by Stora Enso Oyj's Annual General Meeting and the organising meeting of the Board of Directors

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024

SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024
Related companies:  SK bioscience Co.,Ltd

Spectrum Dynamics is proud to announce the Installation of the VERITON-CT SPECT/CT imaging system at European Leading Cancer Center, Gustave Roussy

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024

Immuno-Oncology Therapies: In-Depth Analysis of the Rapidly Evolving Landscape in Next-Generation Cancer Treatment

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024

MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  MediciNova, Inc.

Sosei Heptares Regains Full Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Nxera Pharma Co., Ltd.

Sosei Heptares Doses First Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Nxera Pharma Co., Ltd.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑